Benefits
Easier on the stomach than ascorbic acid
In a double-blind crossover study of 50 adults sensitive to acidic foods, 1,000 mg of vitamin C a day as Ester-C for 3 days led to fewer stomach-area complaints than the same dose of ascorbic acid (33 versus 55 reported events), and 72% versus 54% rated it very well tolerated. That may suit people who find plain vitamin C upsetting.
Immune support
Vitamin C is an essential nutrient for normal immune function, and Ester-C supplies it. In one 60-day placebo-controlled winter trial in 168 adults, the group taking the calcium ascorbate supplement (identified as Ester-C in a later review) reported fewer colds (37 versus 50) and shorter severe symptoms (1.8 versus 3.1 days). This older trial has not been repeated.
Vitamin C levels in white blood cells
In small single-dose crossover studies co-authored by the brand owner's staff, 1,000 mg of Ester-C left more vitamin C in white blood cells at 24 hours than ascorbic acid, while blood plasma levels were similar. A 2024 study of 93 adults found no difference at 250 mg and only some differences at 500 mg. Whether this changes how well people fight infections has not been tested.
Mechanism of action
Buffered ascorbate delivery
Calcium ascorbate is the calcium salt of vitamin C, so it is less acidic than ascorbic acid while delivering the same ascorbate the body uses. Ester-C also contains small amounts of vitamin C metabolites such as dehydroascorbate and calcium threonate. Lab and animal work suggested threonate helps cells take up vitamin C, which is the basis for the brand's white blood cell claims.
Antioxidant and cofactor roles
Vitamin C is an antioxidant that helps regenerate other antioxidants, supports the work of immune cells such as neutrophils, and is a cofactor in making collagen and some neurotransmitters. These roles belong to vitamin C in general, not to Ester-C in particular.
Clinical trials
Two randomized, double-blind crossover studies giving a single 250 mg or 500 mg dose of vitamin C as calcium ascorbate or ascorbic acid, measuring blood and white blood cell vitamin C, neutrophil function and lymphocyte markers over 32 hours. Funded by The Bountiful Co. (Dickerson et al. 2024, Nutrients)
93 healthy adults (46 in the 250 mg study, 47 in the 500 mg study).
At 250 mg there were no significant differences between the two forms in any primary or secondary outcome. At 500 mg, calcium ascorbate was followed by higher plasma dehydroascorbic acid, greater neutrophil activity in the first 8 hours and more of some natural killer cells; the authors called the study preliminary. These are laboratory immune measures after one dose, not infection outcomes.
Randomized, double-blind crossover study: 1,000 mg of vitamin C a day as Ester-C or as ascorbic acid for 3 days each, separated by a 3-day washout, with stomach-area side effects recorded in a diary. (Gruenwald et al. 2006, Adv Ther)
50 healthy adults who were sensitive to acidic foods.
28 of 50 people reported 88 mild to moderate stomach-area side effects in total: 33 after Ester-C and 55 after ascorbic acid. Tolerability was rated very good by 72% on Ester-C and 54% on ascorbic acid (P<.05). Treatment periods were only 3 days, in a selected group.
Randomized, double-blind, placebo-controlled crossover study: single 1,000 mg doses of Ester-C, ascorbic acid or placebo, with plasma and white blood cell vitamin C measured over 24 hours. The authors worked for NBTY, which made Ester-C. (Mitmesser et al. 2016, Springerplus)
36 adults aged 18 to 60.
Plasma vitamin C did not differ between Ester-C and ascorbic acid, though the peak plasma level was higher with Ester-C. The percent change in white blood cell vitamin C was higher with Ester-C than ascorbic acid at 8 and 24 hours. An earlier 15-man study (Moyad 2008) reported a similar 24-hour result. Neither study measured health outcomes.
Randomized, double-blind, placebo-controlled trial: two tablets a day of a vitamin C supplement or placebo for 60 days between November and February, with colds and symptoms recorded in a daily diary. A 2025 review identifies the product as Ester-C. (Van Straten et al. 2002, Adv Ther)
168 adult volunteers.
The vitamin C group reported fewer colds (37 versus 50, P<.05), fewer days with a cold (85 versus 178) and a shorter duration of severe symptoms (1.8 versus 3.1 days). Colds were self-reported, and the result has not been repeated with Ester-C.